Publications Categories All categoriesNewslettersPodcastsPosition & Policy PapersReportsStatementsConsultation ResponsesNews ReleaseOpinion Topic Topic TopicAll Topics2024 EU ElectionsAccess to MedicinesAgriculture & FoodAlcoholAntimicrobial Resistance (AMR)CancerChild HealthClean Air, Transport & CitiesClean Cooking & HeatingClimate CrisisDigital HealthDiscriminationEPHA NewsEurope and HealthHealth WorkforceHuman RightsMental HealthNon Communicable Diseases (NCDs)ObesityPandemics & Infectious DiseasesPartnershipsRoma HealthSocial Determinants of HealthSustainabilityTobaccoTrade & HealthUniversal Health Coverage Policy Policy PolicyAll PoliciesHealthy EnvironmentsHealthcare DeliveryHealth EquityHealth Systems and EconomyGlobal Public HealthDigital TransformationPolitics and Health Search Search Search Clear October 28, 2024EPHA Statement at the UN High Level Meeting on AMR at UNGA 79, New YorkOn September 26, 2024, EPHA attended the High-Level Meeting on Antimicrobial Resistance (AMR) at the...Antimicrobial Resistance (AMR)Healthcare DeliveryStatementsMarch 5, 2024Extended periods of data protection are not the best solution for either health budgets or access to medicines for allThe patients, healthcare users, and public health organisations we represent are extremely concerned about the...Access to MedicinesHealthcare DeliveryStatementsDecember 5, 2023Health Equity Feed | Mental health of refugees and migrants, housing accessibility for Roma, and moreEPHA’s Health Equity Feed brings you the latest news, events, and research on health equity...Health EquityHealthcare DeliveryMental HealthNewslettersRoma HealthSeptember 29, 2023EPHA’s Recommendations for the European Pharmaceutical PackageIn this short paper, we provide targeted recommendations to the current proposal on issues related...Access to MedicinesHealthcare DeliveryPosition & Policy PapersAugust 31, 2023Why you should care about Substances of Human Origin (SoHO)?In a world and time when health and healthcare are mainly approached from a commercial...Access to MedicinesHealth Systems and EconomyHealthcare DeliveryOpinionJune 26, 2023Improving the transparency of clinical trials in the EUOn 22 and 23 June 2023, EPHA attended the kick-off workshop of the multistakeholder platform...Europe and HealthHealthcare DeliveryReportsJune 1, 2023EPHA Newsletter | Exploring elements of the EU’s pharmaceutical legislationDeveloped in 1965, the first EU pharmaceutical legislation was a response to the tragic consequences...Access to MedicinesHealthcare DeliveryNewslettersMay 31, 2023Will transparency of R&D costs lead to more affordable medicines?Without clear knowledge of pharmaceutical R&D costs, it is virtually impossible for regulators to design...Access to MedicinesHealthcare DeliveryOpinionMay 31, 2023What could change in the fight against medicine shortages in Europe?With the COVID-19 pandemic and the multiplication of antibiotic supply disruptions, the fight against medicine...Access to MedicinesHealthcare DeliveryOpinionMay 31, 2023Academic development of medicines – a path to solving unmet medical needsBy Dr Ward Rommel, Chair, Access to Medicines Task Force of Association of European Cancer...Access to MedicinesHealthcare DeliveryOpinionApril 26, 2023Revising the EU pharmaceutical legislation and putting People before (Pharma) ProfitsEPHA welcomes the European Commission’s proposal and calls for a balanced debate so that the...Access to MedicinesHealthcare DeliveryNews ReleasePolitics and HealthApril 12, 2023Why should one care about the new EU pharma law?Have you ever been to the pharmacy and couldn’t find the medicine you were looking...Access to MedicinesHealthcare DeliveryPodcastsPolitics and HealthMarch 29, 2023Letter to Commission President on the delayed publication of the EU pharmaceutical legislation revisionThis new postponement is jeopardising the adoption of a balanced, fair, and robust pharmaceutical framework...Access to MedicinesEurope and HealthHealthcare DeliveryStatementsMarch 9, 2023CSOs call on the European Commission to publish revised EU pharmaceutical legislation no later than in March 2023Brussels, 9 March 2023 Dear Commissioner Kyriakides, We, the signatory organisations representing civil society, patients,...Access to MedicinesHealthcare DeliveryStatementsMarch 7, 2023EPF and EPHA met with Commissioners Schinas and Kyriakides to discuss the ongoing pharmaceutical legislation revision and medicine shortagesBrussels, 7 March 2023 Yesterday afternoon, the European Public Health Alliance (EPHA) and the European...Access to MedicinesHealthcare DeliveryNews ReleaseFebruary 28, 2023EPHA’s contribution to the WHO Europe Access to Novel Medicines PlatformEPHA participated in an online consultation and submitted comments to the WHO Europe on their...Access to MedicinesConsultation ResponsesHealthcare DeliveryFebruary 10, 2023Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationThe transferable exclusivity voucher is a costly, complex and untested incentive for new antibiotics. It...Access to MedicinesHealthcare DeliveryPosition & Policy PapersJanuary 25, 2023Joint letter | The shortage of antibiotics should be considered a “major event”To the EMA Executive DirectorTo the members of the Executive Steering Group on Shortages and...Access to MedicinesHealthcare DeliveryStatements Load more Get the EPHA Newsletter The best of our activities, right in your inbox! SUBSCRIBE Get the EPHA Newsletter SUBSCRIBE
October 28, 2024EPHA Statement at the UN High Level Meeting on AMR at UNGA 79, New YorkOn September 26, 2024, EPHA attended the High-Level Meeting on Antimicrobial Resistance (AMR) at the...Antimicrobial Resistance (AMR)Healthcare DeliveryStatements
March 5, 2024Extended periods of data protection are not the best solution for either health budgets or access to medicines for allThe patients, healthcare users, and public health organisations we represent are extremely concerned about the...Access to MedicinesHealthcare DeliveryStatements
December 5, 2023Health Equity Feed | Mental health of refugees and migrants, housing accessibility for Roma, and moreEPHA’s Health Equity Feed brings you the latest news, events, and research on health equity...Health EquityHealthcare DeliveryMental HealthNewslettersRoma Health
September 29, 2023EPHA’s Recommendations for the European Pharmaceutical PackageIn this short paper, we provide targeted recommendations to the current proposal on issues related...Access to MedicinesHealthcare DeliveryPosition & Policy Papers
August 31, 2023Why you should care about Substances of Human Origin (SoHO)?In a world and time when health and healthcare are mainly approached from a commercial...Access to MedicinesHealth Systems and EconomyHealthcare DeliveryOpinion
June 26, 2023Improving the transparency of clinical trials in the EUOn 22 and 23 June 2023, EPHA attended the kick-off workshop of the multistakeholder platform...Europe and HealthHealthcare DeliveryReports
June 1, 2023EPHA Newsletter | Exploring elements of the EU’s pharmaceutical legislationDeveloped in 1965, the first EU pharmaceutical legislation was a response to the tragic consequences...Access to MedicinesHealthcare DeliveryNewsletters
May 31, 2023Will transparency of R&D costs lead to more affordable medicines?Without clear knowledge of pharmaceutical R&D costs, it is virtually impossible for regulators to design...Access to MedicinesHealthcare DeliveryOpinion
May 31, 2023What could change in the fight against medicine shortages in Europe?With the COVID-19 pandemic and the multiplication of antibiotic supply disruptions, the fight against medicine...Access to MedicinesHealthcare DeliveryOpinion
May 31, 2023Academic development of medicines – a path to solving unmet medical needsBy Dr Ward Rommel, Chair, Access to Medicines Task Force of Association of European Cancer...Access to MedicinesHealthcare DeliveryOpinion
April 26, 2023Revising the EU pharmaceutical legislation and putting People before (Pharma) ProfitsEPHA welcomes the European Commission’s proposal and calls for a balanced debate so that the...Access to MedicinesHealthcare DeliveryNews ReleasePolitics and Health
April 12, 2023Why should one care about the new EU pharma law?Have you ever been to the pharmacy and couldn’t find the medicine you were looking...Access to MedicinesHealthcare DeliveryPodcastsPolitics and Health
March 29, 2023Letter to Commission President on the delayed publication of the EU pharmaceutical legislation revisionThis new postponement is jeopardising the adoption of a balanced, fair, and robust pharmaceutical framework...Access to MedicinesEurope and HealthHealthcare DeliveryStatements
March 9, 2023CSOs call on the European Commission to publish revised EU pharmaceutical legislation no later than in March 2023Brussels, 9 March 2023 Dear Commissioner Kyriakides, We, the signatory organisations representing civil society, patients,...Access to MedicinesHealthcare DeliveryStatements
March 7, 2023EPF and EPHA met with Commissioners Schinas and Kyriakides to discuss the ongoing pharmaceutical legislation revision and medicine shortagesBrussels, 7 March 2023 Yesterday afternoon, the European Public Health Alliance (EPHA) and the European...Access to MedicinesHealthcare DeliveryNews Release
February 28, 2023EPHA’s contribution to the WHO Europe Access to Novel Medicines PlatformEPHA participated in an online consultation and submitted comments to the WHO Europe on their...Access to MedicinesConsultation ResponsesHealthcare Delivery
February 10, 2023Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationThe transferable exclusivity voucher is a costly, complex and untested incentive for new antibiotics. It...Access to MedicinesHealthcare DeliveryPosition & Policy Papers
January 25, 2023Joint letter | The shortage of antibiotics should be considered a “major event”To the EMA Executive DirectorTo the members of the Executive Steering Group on Shortages and...Access to MedicinesHealthcare DeliveryStatements
